The proposal, which comes soon after a draft national pharma policy, marks continued government activism to reduce costs of medical care and control insurance payouts in view of steep treatment and hospitalisation expenses in the private sector. Currently, only a few critical medical devices are under indirect price control and 80% of all devices are imported products.
Read More Click Here
from India News | Latest News Headlines & Live Updates from India - Times of India
via IFTTT
No comments:
Post a Comment